Search results
Results from the WOW.Com Content Network
Whistle's first product, an activity monitor for dogs that tracked their exercise, was released in 2013. [4] The company raised an additional $10 million in a Series A funding round and $15 million in Series B. [1] [5] A February 2014 agreement with PetSmart placed the Whistle device in all the company's stores and led to co-marketing efforts. [6]
However, data collected from various field tests support the conclusion that the Fido explosives detector possesses TNT detection capabilities at least comparable to that of a trained sniffer dog. In addition, advocates for the device have argued that the Fido system allows for explosives detection in situations better suited for machines than ...
The M44 cyanide device (also called a cyanide gun, cyanide trap, or canid pest ejector) is used to kill coyotes, feral dogs, and foxes. It is made from four parts: a capsule holder wrapped with cloth or other soft material, a small plastic capsule containing 0.88 grams of sodium cyanide , a spring-powered ejector, and a 5–7 inches (130–180 ...
These are all vet approved. If your dog is a chewer, you won't want to miss this video that veterinarian Adam Christman shared on Saturday, March 23rd.
The big day for canine competition is coming — and it will showcase some of the finest individuals of the finest breeds.
Dogs do not consistently age seven times as quickly as humans. Aging in dogs varies widely depending on the breed; certain breeds, such as giant dog breeds and English bulldogs, have much shorter lifespans than average. [39] Most dogs reach adolescence by one year old; smaller and medium-sized breeds begin to age more slowly in adulthood. [40]
amitriptyline – tricyclic antidepressant used to treat separation anxiety, excessive grooming dogs and cats; amlodipine – calcium channel blocker used to decrease blood pressure; amoxicillin – antibacterial; apomorphine – emetic (used to induce vomiting) artificial tears – lubricant eye drops used as a tear supplement
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.